A source-linked abstract prepared once when this article was collected.
NEWS ABSTRACT10/23/2026 · one shared analysis
Anthropic is inviting principal investigators and research groups at academic institutions, nonprofits, or government labs to propose 8–12 week special projects using Claude in life sciences areas such as causal human biology, molecular biology, medicinal chemistry, drug discovery, and clinical science. Anthropic researchers will work directly with selected guest investigators at no cost, with outputs published and open-sourced. Applicants keep rights to their data, and applications are open for about 14 days.
Key takeaways
- Selected guest investigators work directly with Anthropic researchers for 8–12 weeks, with models and harnesses provided at no cost.
- Outputs such as analyses, artifacts, and tools are to be published, with accompanying data and code open-sourced.
- Guest investigators retain rights to their data and to any independent follow-on research.
- Applicants must use only publicly available information and are not asked to provide their data.
Why it matters
The program offers free access to Claude and direct researcher collaboration for life sciences groups, and commits results to public release, potentially expanding scientific tooling for the research community.
Read with care
Source claims not independently checked; the program is described as a one-time open call and may be expanded or changed later, and selection criteria beyond the stated requirements are not specified.
life sciencesanthropicresearch collaborationclaudebiology
Links in the source
Public links observed in the fetched page. Inclusion does not verify or endorse the destination.
Earlier coverage
Source links and topic overlap from the AINewsIQ archive. These connections do not imply a claim is confirmed.
Discussion
Comments are reviewed before publication. Discuss the evidence, not the person.
No published comments yet.
Reader discussion opens with accounts. You can read the original source and published comments now.